Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
September 22, 2025 16:00 ET | Source: Until Labs

Until Labs Announces $58M Series A Funding Round, to Develop an Organ Cryopreservation Product for Transplant Patients and Surgeons

Until Labs announces Series A funding to develop an organ cryopreservation product for transplant patients and surgeons.
September 17, 2025 09:00 ET | Source: Paragonix Technologies, Inc.

Donor Network West Expands Kidney Transplant Opportunities with Paragonix KidneyVault® Preservation System

WALTHAM, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced a strategic partnership with Donor...
September 02, 2025 09:00 ET | Source: Paragonix Technologies, Inc.

KidneyVault Perfusion Technology Expands the Donor Pool by Increasing Access to Medically Complex Kidneys

WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ preservation and transplant logistics, reports an extraordinary case at the Tampa General...
August 29, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
August 14, 2025 16:20 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
August 06, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
July 30, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Eledon to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at WTC
July 17, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at WTC 2025
June 26, 2025 05:56 ET | Source: Research and Markets

$19 Bn Organ Transplantation Market Analysis by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast to 2030

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplantation Market by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast to 2030" report has been added to ...